A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

Recruiting

Phase 1

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

Sponsor:

Rush University Medical Center

Code:

NCT06229392

Conditions

Breast Cancer

Breast Cancer Triple Negative

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fluzone Quadrivalent

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-07-12. This information was provided to ClinicalTrials.gov by Rush University Medical Center on 2024-06-26.